4//SEC Filing
Iannone Robert 4
Accession 0001805688-25-000013
CIK 0001232524other
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 6:58 PM ET
Size
6.8 KB
Accession
0001805688-25-000013
Insider Transaction Report
Form 4
Iannone Robert
EVP, Global Head of R&D & CMO
Transactions
- Award
Ordinary Shares
2025-01-17+7,506→ 69,947 total - Tax Payment
Ordinary Shares
2025-01-17$122.62/sh−2,181$267,434→ 67,766 total
Footnotes (3)
- [F1]Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on March 3, 2022. The performance-based vesting requirements applicable to such awards were satisfied on January 17, 2025, which represents the date on which the level of performance attained was certified.
- [F2]The Reporting Person acquired 167 ordinary shares on May 31, 2024 and 48 ordinary shares on November 29, 2024 under a Section 423 Employee Stock Purchase Plan.
- [F3]Shares to be withheld from the vesting and distribution of performance award shares to satisfy the reporting person's tax obligations.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001737329
Filing Metadata
- Form type
- 4
- Filed
- Jan 21, 7:00 PM ET
- Accepted
- Jan 22, 6:58 PM ET
- Size
- 6.8 KB